Drug Type Small molecule drug |
Synonyms RSS0393 |
Target |
Action inhibitors |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Plaque psoriasis | Phase 3 | China | 01 Apr 2026 | |
| Mild Atopic Dermatitis | Phase 2 | China | 17 Sep 2025 | |
| Moderate Atopic Dermatitis | Phase 2 | China | 17 Sep 2025 | |
| Chronic large plaque psoriasis | Phase 2 | - | 01 Apr 2025 | |
| Psoriasis | Phase 1 | China | 01 Mar 2024 |





